A detailed history of Prudential Financial Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 644,105 shares of MRVI stock, worth $3.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
644,105
Previous 597,882 7.73%
Holding current value
$3.35 Million
Previous $4.28 Million 25.05%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.84 - $9.73 $316,165 - $449,749
46,223 Added 7.73%
644,105 $5.35 Million
Q2 2024

Aug 13, 2024

BUY
$6.87 - $11.34 $4.11 Million - $6.78 Million
597,882 New
597,882 $4.28 Million
Q4 2023

Feb 13, 2024

BUY
$4.7 - $9.87 $257,151 - $540,017
54,713 Added 25.46%
269,608 $1.77 Million
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $2,641 - $3,713
289 Added 0.13%
214,895 $2.15 Million
Q2 2023

Aug 11, 2023

SELL
$12.09 - $15.0 $136,459 - $169,305
-11,287 Reduced 5.0%
214,606 $2.67 Million
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $599,293 - $760,304
46,135 Added 25.67%
225,893 $3.16 Million
Q4 2022

Feb 14, 2023

BUY
$12.5 - $24.78 $2.11 Million - $4.18 Million
168,699 Added 1525.45%
179,758 $0
Q3 2022

Nov 04, 2022

SELL
$20.6 - $30.37 $25.3 Million - $37.2 Million
-1,226,043 Reduced 99.11%
11,059 $282,000
Q2 2022

Aug 15, 2022

BUY
$26.05 - $37.48 $19.2 Million - $27.6 Million
737,313 Added 147.52%
1,237,102 $35.1 Million
Q1 2022

May 13, 2022

BUY
$24.46 - $40.92 $11.8 Million - $19.8 Million
484,257 Added 3117.8%
499,789 $17.6 Million
Q4 2021

Feb 14, 2022

BUY
$35.0 - $45.94 $543,620 - $713,540
15,532 New
15,532 $652,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $684M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.